|
FDA application has been lodged - approval was
anticipated around late April.
Everyone here knows my thoughts on this
one.
My expert TA analysis - higher highs, higher
lows and poised for another upturn especially in consideration of anticipated
FDA approval.
----- Original Message -----
Sent: Monday, April 19, 2004 5:46
AM
Subject: [sharechat] VSG Upside Potential
Looking Good.
Latest April 04 Aegis Equities Comments.
Through the
acquisition of Visiomed AG, VSG has not only secured full
control over the
microDERM device but also has rights to any other IP
developed within the
German company. This includes some interesting surgical
navigation
technology that VSG may be able to commercialise in the future.
The
Funhaler provides a potential spinout product that can help fund VSG's
other ventures.
VSG has managed to build its patent portfolio over
the last year, an
important first step to eventual commercialisation. A
recent study was
published in the influential British Journal of
Dermatology detailing the
diagnostic use of the MicroDERM system and this
should help it achieve US
regulatory approval as higher value diagnostic
device. VSG also forged
closer links with Siemens AG, one of the world's
largest and most recognised
engineering and medical imaging companies,
announcing an exclusive
Australian dealership for a range of Siemens
medical imaging systems. VSG is
also a significant participating
collaborator with Siemens in the
development of ultrasound-based surgical
navigation systems for spinal
procedures.
Lazy
Haggis
_________________________________________________________________
Watch
LIVE baseball games on your computer with MLB.TV, included with MSN
Premium!
http://join.msn.com/?page=features/mlb&pgmarket=en-us/go/onm00200439ave/direct/01/
----------------------------------------------------------------------------
To
remove yourself from this list, please use the form at
http://www.sharechat.co.nz/chat/forum/
|
See IRG research reports
